申请人:ARIXA PHARMACEUTICALS, INC.
公开号:US20200102307A1
公开(公告)日:2020-04-02
Derivatives of relebactam, therapeutic methods of using the derivatives of relebactam, particularly in combination with β-lactam antibiotics and pharmaceutical compositions thereof are disclosed. The derivatives of relebactam are suitable for oral administration.
Relebactam的衍生物、使用Relebactam的衍生物的治疗方法,特别是与β-内酰胺类抗生素结合使用以及其制药组合物已被披露。Relebactam的衍生物适合口服给药。